Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS??? DEFICIT

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT - 3 months ended Mar. 31, 2017 - USD ($)
Total
Common Stock [Member]
Additional Paid In Capital [Member]
Stockholder Note Receivable [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2016 $ (329,421) $ 101,309 $ 78,106,645 $ (58,824) $ 120,187 $ (78,598,738)
Balance (in shares) at Dec. 31, 2016   10,130,883        
Stock-Based Compensation 276,901   276,901      
Issuance of Common Stock in Offering, Net of Offering Costs 1,823,933 $ 6,421 1,817,512      
Issuance of Common Stock in Offering, Net of Offering Costs (in shares)   642,150        
Exercise of Common Stock Options 1,841 $ 11 1,830      
Exercise of Common Stock Options (in shares)   1,083        
Issuance of Restricted Stock 0 $ 1,040 (1,040)      
Issuance of Restricted Stock (in shares)   104,000        
Foreign Currency Translation Adjustment 65       65  
Net Loss (2,919,654)         (2,919,654)
Balance at Mar. 31, 2017 $ (1,146,335) $ 108,781 $ 80,201,848 $ (58,824) $ 120,252 $ (81,518,392)
Balance (in shares) at Mar. 31, 2017   10,878,116